{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:10:31Z","timestamp":1778710231805,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["HHSH250-2019-00001C"],"award-info":[{"award-number":["HHSH250-2019-00001C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["SCH:\/2123683"],"award-info":[{"award-number":["SCH:\/2123683"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jss.2025.04.026","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:31:44Z","timestamp":1748377904000},"page":"203-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Combined Thymoglobulin and Interleukin-2 Receptor Antagonist Induction Therapy in Kidney Transplantation Is Associated With Worse Delayed Graft Function, Acute Rejection, Graft Loss, and Mortality"],"prefix":"10.1016","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1735-8453","authenticated-orcid":false,"given":"Macrae","family":"Kozody","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnav","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamsini","family":"Katasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Herdrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoru","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geovani","family":"Faddoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2025.04.026_bib1","series-title":"2024 USRDS annual data report: epidemiology of kidney disease in the United States","year":"2024"},{"key":"10.1016\/j.jss.2025.04.026_bib2","series-title":"OPTN\/SRTR 2022 annual data report","year":"2024"},{"key":"10.1016\/j.jss.2025.04.026_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.34971","article-title":"Survival benefit of first single-organ deceased donor kidney transplantation compared with long-term dialysis across ages in transplant-eligible patients with kidney failure","volume":"5","author":"Strohmaier","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jss.2025.04.026_bib4","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1111\/ajt.16463","article-title":"Long-term kidney transplant graft survival-Making progress when most needed","volume":"21","author":"Poggio","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2025.04.026_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2025.04.026_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120964061","article-title":"Incidence, risk factors, and outcomes of kidney transplant recipients treated with both basiliximab and antithymocyte globulin","volume":"7","author":"Jeong","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.jss.2025.04.026_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000371728","article-title":"Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study","volume":"41","author":"Gentile","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jss.2025.04.026_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2215\/CJN.01841105","article-title":"Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation","volume":"1","author":"Ruggenenti","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jss.2025.04.026_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.trim.2016.11.004","article-title":"Randomized trial of rATg\/Daclizumab vs. rATg\/Alemtuzumab as dual induction therapy in renal transplantation: results at 8years of follow-up","volume":"40","author":"Ciancio","year":"2017","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jss.2025.04.026_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001190","article-title":"Clinical correlates and outcomes of dual basiliximab and antithymocyte globulin induction in kidney transplant recipients: a national study","volume":"7","author":"Lam","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jss.2025.04.026_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2017.06.005","article-title":"Thymoglobuline plus basiliximab a mixed cocktail to start?","volume":"43-44","author":"Spagnoletti","year":"2017","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jss.2025.04.026_bib12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.transproceed.2010.03.073","article-title":"Induction with basiliximab plus thymoglobulin is effective and safe in old-for-old renal transplantation: six-month results of a prospective clinical study","volume":"42","author":"Favi","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jss.2025.04.026_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051392","article-title":"Risk factors of rejection in renal transplant recipients: a narrative review","volume":"11","author":"Oweira","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jss.2025.04.026_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12101557","article-title":"Delayed graft function in kidney transplant: risk factors, consequences and prevention strategies","volume":"12","author":"Ponticelli","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jss.2025.04.026_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12882-022-02777-9","article-title":"Duration of delayed graft function and its impact on graft outcomes in deceased donor kidney transplantation","volume":"23","author":"Budhiraja","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jss.2025.04.026_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1523-1755.2000.00235.x","article-title":"Delayed graft function influences renal function, but not survival","volume":"58","author":"Boom","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jss.2025.04.026_bib17","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients","volume":"20","author":"No\u00ebl","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jss.2025.04.026_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00007890-200003150-00021","article-title":"Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring","volume":"69","author":"Djamali","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jss.2025.04.026_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/tri.12696","article-title":"Predictors and outcomes of delayed graft function after living-donor kidney transplantation","volume":"29","author":"Redfield","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.jss.2025.04.026_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ctr.12662","article-title":"Kidney transplantation in the Hispanic population","volume":"30","author":"Matsuoka","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jss.2025.04.026_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000479480","article-title":"Health disparities in kidney transplantation for African Americans","volume":"46","author":"Harding","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jss.2025.04.026_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2025.04.026_bib23","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.transproceed.2023.08.021","article-title":"Significant increase in cytomegalovirus (CMV) infection in solid organ transplants associated with increased use of thymoglobulin as induction therapy?","volume":"55","author":"Romao","year":"2023","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jss.2025.04.026_bib24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1086\/597089","article-title":"Infectious complications of antilymphocyte therapies in solid organ transplantation","volume":"48","author":"Issa","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480425002410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480425002410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:33:12Z","timestamp":1778707992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480425002410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":24,"alternative-id":["S0022480425002410"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2025.04.026","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Thymoglobulin and Interleukin-2 Receptor Antagonist Induction Therapy in Kidney Transplantation Is Associated With Worse Delayed Graft Function, Acute Rejection, Graft Loss, and Mortality","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2025.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}